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Abstract
Allele-specific gene silencing by RNA interference (RNAi) is therapeutically useful for specifically inhibiting the expression of
disease-associated alleles without suppressing the expression of corresponding wild-type alleles. To realize such allele-
specific RNAi (ASP-RNAi), the design and assessment of small interfering RNA (siRNA) duplexes conferring ASP-RNAi is vital;
however, it is also difficult. In a previous study, we developed an assay system to assess ASP-RNAi with mutant and wild-
type reporter alleles encoding the Photinus and Renilla luciferase genes. In line with experiments using the system, we
realized that it is necessary and important to enhance allele discrimination between mutant and corresponding wild-type
alleles. Here, we describe the improvement of ASP-RNAi against mutant alleles carrying single nucleotide variations by
introducing base substitutions into siRNA sequences, where original variations are present in the central position. Artificially
mismatched siRNAs or short-hairpin RNAs (shRNAs) against mutant alleles of the human Prion Protein (PRNP) gene, which
appear to be associated with susceptibility to prion diseases, were examined using this assessment system. The data
indicates that introduction of a one-base mismatch into the siRNAs and shRNAs was able to enhance discrimination
between the mutant and wild-type alleles. Interestingly, the introduced mismatches that conferred marked improvement in
ASP-RNAi, appeared to be largely present in the guide siRNA elements, corresponding to the ‘seed region’ of microRNAs.
Due to the essential role of the ‘seed region’ of microRNAs in their association with target RNAs, it is conceivable that
disruption of the base-pairing interactions in the corresponding seed region, as well as the central position (involved in
cleavage of target RNAs), of guide siRNA elements could influence allele discrimination. In addition, we also suggest that
nucleotide mismatches at the 39-ends of sense-strand siRNA elements, which possibly increase the assembly of antisense-
strand (guide) siRNAs into RNA-induced silencing complexes (RISCs), may enhance ASP-RNAi in the case of inert siRNA
duplexes. Therefore, the data presented here suggest that structural modification of functional portions of an siRNA duplex
by base substitution could greatly influence allele discrimination and gene silencing, thereby contributing to enhancement
of ASP-RNAi.
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Introduction
RNA interference (RNAi) is the process of sequence-specific
posttranscriptionalgene silencing inducedbydouble-stranded RNAs
(dsRNAs)homologousto thesilencedgene,anditiscurrentlyused as
a powerful tool to suppress the expression of genes of interest [1,2].
Introduced or generated dsRNAs are subjected to digestion by an
RNase III enzyme, Dicer, into 21–25 nucleotide (nt) RNA duplexes
[3]. The resultant RNA duplexes, referred to as small interfering
RNA (siRNA) duplexes, are unwound, and single-stranded siRNA
elements can then be incorporated into RNA-induced silencing
complexes (RISCs) to function assequence-specificmediators. These
are referred to as guide siRNA elements [1,2,4].
In mammals, RNAi can be induced by direct introduction of
chemically synthesized siRNA duplexes into cells, or by generation
of siRNA duplexes using short-hairpin RNA (shRNA) expression
vectors. Applications are expanding in various fields of science,
with the potential therapeutic use of RNAi in medical science and
pharmacogenesis being particularly promising [1,5–8].
Allele-specific gene silencing by RNAi (allele-specific RNAi:
ASP-RNAi) is an advanced application of RNAi techniques that
allows the expression of an allele of interest to be specifically
inhibited [9]. ASP-RNAi would thus be therapeutically very
useful, as it can specifically suppress the expression of alleles
causing disease without inhibiting the expression of corresponding
wild-type alleles [10–17]. To induce such ASP-RNAi, it is
necessary to design siRNAs that exhibit strong allele-specific gene
silencing; thus, siRNAs must be designed such that they are able to
carry nucleotide variations characterizing target disease alleles and
to discriminate the target alleles from corresponding wild-type
alleles. In addition, qualitative and quantitative evaluation of such
designed siRNAs on allele-specific gene silencing is required.
In a previous study, we developed an assay system to assess
ASP-RNAi with mutant and wild-type reporter alleles encoding
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designed siRNAs and short-hairpin RNAs (shRNAs) against
mutant alleles in allele-specific gene silencing, as well as off-target
silencing against wild-type alleles, can be simultaneously examined
[17]. With amyloid precursor protein (APP) variants (the Swedish-
and London-type variants) related to familial Alzheimer’s disease
[18,19] as model disease alleles, we were able to determine
competent siRNA duplexes conferring ASP-RNAi [17]. Previous
observations have also suggested that enhanced discrimination of
target mutant alleles carrying single nucleotide variations from
wild-type allele RNAs is required for ASP-RNAi.
In the present study, we describe the improvement of ASP-
RNAi against mutant alleles carrying single nucleotide variations.
We introduced base substitutions into siRNA and shRNA
sequences, and examined the effects of the resultant mismatched
siRNAs and shRNAs on ASP-RNAi by means of our assay system.
The results presented here suggest that base substitutions
introduced into certain portions of siRNA and shRNA sequences
may contribute to enhancement of ASP-RNAi.
Results
ASP-RNAi against PRNP alleles carrying single nucleotide
variations
In a previous study, we established an assessment system for
siRNA duplexes conferring ASP-RNAi [17]. This system
depends on two reporter alleles encoding the Photinus and Renilla
luciferase genes carrying mutant and wild-type allelic sequences in
their 39-UTRs. Briefly, using this system, the effects of test
siRNA duplexes against mutant alleles in allele-specific silencing,
as well as off-target silencing against wild-type alleles, can be
examined under heterozygous conditions generated by cotrans-
fecting the reporter alleles and siRNA duplexes into cultured
human cells.
In this study, we focused on the human Prion Protein (PRNP)
gene, which is known to possess a number of single nucleotide
variations [20,21]. We selected three PRNP variants, which are
also followed by amino acid substitutions (P102L, P105L, and
D178N) and appear to be associated with susceptibility to various
prion diseases such as Gerstmann-Stra ¨ussler-Scheinker disease
(GSS) and fatal familial insomnia (FFI) [22–25]. We constructed
three mutant reporter alleles, designated the PRNP-P102L, PRNP-
P105L, and PRNP-D178N alleles, and their corresponding wild-
type reporter alleles (Figure 1A). The reporter alleles, synthetic
siRNA duplexes against the mutant alleles (supplementary Table
s1 and supplementary Figure s1), and the beta-galactosidase gene
(control), were cotransfected into HeLa cells; thus, the transfected
cells were artificially heterozygous with the mutant and wild-type
reporter alleles. The effects of the designed siRNA duplexes on
suppression of both the mutant and wild-type alleles were then
simultaneously examined. As shown in Figure 1, the siRNA
duplexes other than siPrnp102(T7), siPrnp102(T8), siPrnp105(T7)
and siPrnp105(T9) were not able to induce significant ASP-RNAi.
Of the four siRNAs just listed, the siPrnp105(T9) duplex appears
to confer ASP-RNAi.
To realize ASP-RNAi against any target alleles, it is important
and necessary to establish techniques for enhancement of allele
discrimination followed by specific digestion against the target
alleles. To address this, we selected siRNA duplexes possessing
strong knockdown potency as candidates for improvement. This is
because the only apparent failure of such siRNAs is being unable
to discriminate target alleles from non-target ones, i.e., ASP-RNAi
may be improved just by reinforcing allele discrimination. Since
RNAi activity appears to be influenced by nucleotide mismatches
Figure 1. Assessment of ASP-RNAi with reporter alleles.( A )
Schematic drawing of reporter alleles. Reporter alleles were constructed
by inserting synthetic oligonucleotides of mutant and wild-type allelic
sequences into the 39-UTRs of the reporter genes driven by the same TK
promoter (indicated by arrows). Assessment of designed siRNA duplexes
against the mutant allele was carried out as described in Materials and
Methods. Effects of designed siRNA duplexes against the PRNP-P102L (B),
PRNP -P105L (C), and PRNP -D178N (D) mutants on ASP-RNAi. Reporter
alleles,synthetic siRNAduplexesagainstthemutantalleles(indicated)and
the b-galactosidase gene (control) were cotransfected into HeLa cells.
Twenty-four hours after transfection, expression levels of the reporter
genes were examined. Levels of either mutant allele (pink boxes) or wild-
type allele (blue boxes) luciferase activity were normalized against the
levels of b-galactosidase activity, and the ratios of mutant and wild-type
luciferase activities in the presence of siRNA duplexes were normalized
against the control ratios obtained in the presence of siControl duplex
(siCont). Data are averages of at least three independent determinations.
Error bars represent standard deviations.
doi:10.1371/journal.pone.0002248.g001
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one-base substitution into the selected siRNAs (Figures 2A and E;
supplementary Table s2) and examined the effects of such
mismatched siRNA duplexes using our assessment system. It
should be noted that the resultant mismatched siRNAs give rise to
one nucleotide mismatches against the target mutant allele, and
more importantly, two nucleotide mismatches against the wild-
type allele (the artificially introduced mismatch and the original
variation). Accordingly, we expected that such mismatched
siRNAs would exhibit better discrimination between target mutant
and wild-type alleles, and only suppress the expression of the
mutant alleles.
Effects of mismatched siRNA duplexes on ASP-RNAi
against PRNP-P102L and PRNP-P105L alleles
We selected the siPrnp102(T9) and siPrnp105(T10) duplexes
from the first screening of siRNA duplexes against the PRNP
mutant alleles (Figure 1), and introduced base substitutions into
the siRNAs (Figures 2A and E). The resultant mismatched siRNAs
were investigated using the assessment system to determine
whether they could improve ASP-RNAi. To more precisely
determine allele-specific gene silencing, we examined the ratio of
the wild-type allele expression to the mutant allele expression.
Figures 2B and F show the results of the assessment of the
mismatched siPrnp102(T9) and siPrnp105(T10) duplexes, respec-
Figure 2. Assessment of mismatched siPrnp102(T9) and siPrnp105(T10) duplexes on ASP-RNAi. (A, E) Nucleotide sequences of wild-type
and mutant PRNP mRNAs and designed siRNAs. The wild-type and mutant PRNP mRNA sequences around the P102L (A) and P105L (E) variations are
shown and the variations are indicated in red. Designed siRNAs (indicated) are represented based on the sequence of the sense-strand (passenger)
siRNA element; mismatched nucleotides (introduced base substitutions) and the original variations are indicated in blue and red, respectively. The
same sequences as the siPrnp102(T9) or siPrnp105(T10) are represented by thin lines. (B, F) Effects of mismatched siPrnp102(T9) and siPrnp105(T10)
on ASP-RNAi. Mismatched siPrnp102(T9) (B) and siPrnp105(T10) (E) duplexes (indicated) were examined as in Figure 1. The ratio of wild-type allele-
luciferase activity against the mutant allele-luciferase activity (WT/Mut) was also examined to evaluate the improvement in ASP-RNAi. Data are
averages of at least three independent determinations. Error bars represent standard deviations. Expression of the wild-type (C, G) and mutant [P102L
(D) and P105L (H)] PRNP polypeptides (PRNPmut102-V5 and PRNPmut102-V5) in the presence of indicated siRNA duplexes was investigated by
Western blotting using anti-V5 antibody. Expression of a-tubulin was examined as the control.
doi:10.1371/journal.pone.0002248.g002
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substitution into the siRNAs was able to influence allele discrimi-
nation and RNAi activity, (ii) different nucleotide mismatches
appeared to yield different levels of discrimination and inhibition
against either the target mutant or wild-type allele, and (iii) some
base substitutions appeared to confer marked allele discrimination,
resulting in enhancement of ASP-RNAi. It may be of interest that
the expression level of the wild-type allele in the presence of
siPrnp105(T10)-14U was markedly increased, which may have
been caused by the unusual expression level of the control beta-
galactosidase gene, for as yet unknown reasons. Examination of the
ratio of wild-type expression to mutant expression revealed that
the siPrnp102(T9)-12C, -13A, -14U and -17G duplexes (Figure 2B)
and the siPrnp105(T10)-14U and -15U duplexes (Figure 2F)
appear to have markedly improved ASP-RNAi activity. In
addition, when HEK293 cells were used instead of HeLa cells,
similar results were obtained (data not shown).
To further confirm the results, we examined the effects of the
siRNAs on the recognition and inhibition of the bona fide wild-type
and mutant PRNP alleles using their full-length cDNAs. The
pPRNPwt-V5 and pPRNPmut102(or mut105)-V5 expression
plasmids carrying the wild-type and mutant cDNAs, respectively,
were subjected to cotransfection with the siRNAs into HeLa cells,
and the expression of the PRNPwt-V5 or the PRNPmut102(or
mut105)-V5 polypeptide then examined by Western blotting. The
results indicate that while the signal of PRNPwt-V5 in the
presence of siPrnp102(T9) or siPrnp105(T10) was reduced, the
signal intensity of PRNPwt-V5 was increased in the presence of
either siPrnp102(T9)-12C, siPrnp102(T9)-14U or siPrnp105(T10)-
15U (Figures 2C and G; supplementary Figure s2A). As expected,
the mismatched siRNAs still hold a strong knockdown potency
against the mutant PRNPs (Figures 2D and H; supplementary
Figure s2B). These observations agree with the results for the
reporter alleles described above.
Effects of mismatched siRNA duplexes on ASP-RNAi
against PRNP mutant alleles
From the first screening (Figures 1C and D), we also selected the
siPrnp102(T10) and siPrnp178(A9) duplexes and introduced base
substitutions into the siRNAs (supplementary Figures s3A and D).
Assessment of the mismatched siRNAs suggested that, similar to
Prnp102(T9) and Prnp105(T10), introduction of a one-base
substitution into the siRNAs influenced ASP-RNAi activity.
Furthermore, the ratios of wild-type allele expression to mutant
allele expression indicated that the siPrnp102(T10)-13C and
siPrnp178(A9)-13C duplexes have significantly improved ASP-
RNAi activity (supplementary Figures s3B and E). Western blot
analysis indicated that while the PRNPwt-V5 signal was reduced
in the presence of either siPrnp102(T10) or siPrnp178(A9), the
signal was increased in the presence of the mismatched
siPrnp102(T10)-13C or siPrnp178(A9)-13C duplexes (supplemen-
tary Figures s3C and F); thus, the data is also compatible with the
results for the reporter alleles described above.
Effects of shRNA expression plasmids on ASP-RNAi
As short-hairpin RNA (shRNA) expression vectors appear to be
useful for long-term gene silencing [16,27,28], their potential use
in ASP-RNAi is also of interest. We constructed shRNA
expression plasmids for production of the siPrnp102(T9), (T9)-
12C, (T9)-13A, (T9)-14U and (T9)-15U duplexes in cells [desig-
nated sh102(T9), sh102(T9)-12C, sh102(T9)-13A, sh102(T9)-14U,
sh102(T9)-15U plasmids, respectively]. The shRNA expression
plasmids were examined by the assessment system and Western
blotting as described above. As shown in Figure 3, the results
indicate that while the sh102(T9) plasmid induced strong gene
silencing against either the mutant or wild-type allele, the
sh102(T9)-12C, -13A, -14U and -15U plasmids were able to
confer allele-specific gene silencing, which agrees with the data for
synthetic siRNA duplexes (Figure 2). It is noteworthy that the
mismatched shRNA expression plasmids appear to enhance ASP-
RNAi to a greater degree than the corresponding synthetic siRNA
duplexes; of the mismatched plasmids, the sh102(T9)-12C
plasmid, appears to induce strong ASP-RNAi. It is possible that
mismatched shRNA expression plasmids are superior to mis-
matched siRNA duplexes for induction of ASP-RNAi.
Effects of structural modification of siRNA duplexes on
ASP-RNAi
In a previous study, we experienced difficulty in inducing ASP-
RNAi against the London-type amyloid precursor protein (APP)
mutants, in which single nucleotide substitutions followed by
amino acid substitutions (V717I, V717L, V717G) were present [17].
While a few designed siRNAs targeting the mutants appeared to
discriminate between the mutant and the corresponding wild-type
alleles to some degree, most of the siRNAs resulted in weak gene
silencing. This is in contrast to the knockdown potency of siRNAs
targeting the PRNP mutants described above (Figure 1). To
Figure 3. ASP-RNAi with mismatched shRNA expression
plasmids against the PRNP-P102L mutant. (A) sh102(T9),
sh102(T9)-12C, sh102(T9)-14U, sh102(T9)-15U and shCont shRNA
expression plasmids for production of siPrnp102(T9), (T9)-12C, (T9)-
14U and (T9)-15U duplexes and siControl duplex, respectively, were
constructed with reporter alleles and their effects on ASP-RNAi were
examined as in Figure 1. Western blot analysis of the wild-type (B) and
P102L (C) PRNP polypeptides was carried out as in Figure 2.
doi:10.1371/journal.pone.0002248.g003
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that they can gain knockdown potency against the mutants, and
structural modification may also be applicable for achieving such
improvements.
Previous studies showed that fork-siRNA duplexes (F-siRNA
duplexes) carrying two nucleotide mismatches at the 39-ends of the
sense-strand siRNA elements are able to enhance RNAi activity to
a greater degree than conventional siRNA duplexes [29,30].
Accordingly, we investigated whether F-siRNA duplexes improve
ASP-RNAi activity against the London-type APP mutants (Figure 4
and supplementary Table s5). The results indicate that several F-
siRNA duplexes [F-siAPP(A11), (T11), (G11) and (G12) duplexes]
were able to enhance ASP-RNAi to some degree (Figures 4B-D).
Inrelation tothe improvementofASP-RNAi againstthe London-
type APP mutants, we further observed that F-siRNA duplexes, F-
siAPP(T12/C13),targetingtheSwedishAPPmutantcarryingdouble
nucleotide mutations, were able to markedly improve ASP-RNAi
activity, although the conventional siAPP(T12/C13) duplexes
induced little or no RNAi activity (Figure 4E).
Different effects of miR-196a and miR-196b on
recognition of target HOXB8
From the data of the mismatched siPrnp duplexes (Figures 2 and
supplementary Figures s2 and s3) and shPrnp RNAs (Figure 3), it
appears that the base substitutions conferring marked improvement
are largely present inthe region of siRNAs corresponding to the seed
region of microRNA. This suggests that the region corresponding to
the seed region, as well as the central position (where the original
variations are present), of guide siRNAs may play a role in allele
discrimination in allele-specific gene silencing (details in Discussion).
Based onthis, itisof particularinteresttodetermine whetherthe two
regions of bona fide microRNA (miRNA) can contribute to the
regulation of gene expression. From a previous study [31] and an
miRNA database, we focused on miR-196a and miR-196b, both of
which are nearly complementary to part of the 39-UTR sequence of
HOXB8 mRNA. Note that one and two mismatches are present in
thepredictedbase-pairingofHOXB8withmiR-196aandmiR-196b,
respectively (Figure 5A). In addition, one mismatch, which can form
a G:U wobble base-pair, is present in the seed region of both
miRNAs, while the other mismatch (U vs. C) is present in the central
position of miR-196b. We examined whether the mismatches in
miR-196a and miR-196b participate in the recognition of their
target, HOXB8.
To address this, we constructed a reporter plasmid encoding the
Renilla luciferase gene with a part of the HOXB8 sequence in its 39-
UTR. The resultant reporter gene was cotransfected with either
synthetic miR-196a or miR-196b duplex into HeLa cells, and the
expression levels of the reporter gene then examined. The results
(Figure 5B) indicate that miR-196a induced potent inhibition of the
expression of the target reporter gene, whereas miR-196b conferred
moderate levels of suppression against target reporter gene
expression, thus suggesting different levels of recognition against
HOXB8 between miR-196a and miR-196b. Consequently, the
evidence suggests that the mismatches in miR-196a and miR-196b
probably influence the recognition of their target HOXB8 mRNA.
Discussion
Enhancement of ASP-RNAi by mismatched siRNAs
In order to realize and control ASP-RNAi, it is necessary to
design competent siRNAs or shRNAs possessing strong allele
discrimination between target mutant and wild-type alleles,
thereby inducing allele-specific gene silencing. In the case of
ASP-RNAi, designed siRNAs perfectly match target mutant
alleles, but do not correspond with wild-type alleles, i.e.,
mismatched base pairing(s) will occur at variation site(s) between
the siRNAs and wild-type alleles (Figure 6A; wild-type mRNA).
Figure 4. Effects of forked siRNA duplexes on APS-RNAi
against APP mutants. (A) Schematic drawing of conventional and
forked siRNA duplexes. Each box represents a ribonucleotide, and
antisense-stranded siRNA elements are indicated by gray boxes. (B)-(E)
Comparison of ASP-RNAi activities between conventional (Conv.) and
forked (Fork) siRNA duplexes. Assessment of conventional and forked
siRNA duplexes against the London V717I (B), V717F (C), and V717G (D)
APP mutants and the Swedish (E) APP mutant was carried out as
described previously [17]. The ratios of mutant and wild-type luciferase
activities in the presence of siRNA duplexes were normalized against
the control ratio obtained in the presence of siControl duplex. Data are
averages of at least three independent determinations. Error bars
represent standard deviations.
doi:10.1371/journal.pone.0002248.g004
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mismatches in siRNAs on RNAi activities were systematically
examined suggest that nucleotide mismatches are able to influence
RNAi activity [26,32]. Our present and previous studies indicate
that some, but not all, of the designed siRNA duplexes targeting
mutant alleles apparently discriminate the mutant alleles from the
wild-type alleles. Since different siRNAs confer different levels of
RNAi activity depending upon their thermodynamic properties,
the intrinsic knockdown potency may also affect allele discrimi-
nation between target and non-target alleles.
In the present study, we observed an improvement in ASP-RNAi
when siRNAs induced double knockdown of mutant and wild-type
alleles: introduction of a one-base substitution into such siRNAs
carrying the original variations around the central position appeared
to influence allele discrimination and inhibition of target mutant
alleles, although different base substitutions conferred different levels
of discrimination and inhibition (Figure 6B). This phenomenon may
be associated with the thermodynamic properties of the modified
siRNA duplexes. Interestingly, the base substitutions conferring
marked ASP-RNAi appeared to be largely present in the region of
guide siRNAs, corresponding to the seed region of microRNAs.
Since such siRNAs exhibit one and two mismatches against mutant
and wild-type alleles, respectively, we suggest that disruption of base-
pairing interaction in the seed region, as well as the central position,
of the guide siRNAs reduces recognition and/or silencing activity
against wild-type alleles, and that a one-base mismatch in the seed
region of the guide siRNAs against the target mutant alleles hardly
affects gene silencing, i.e., potent RNAi activity against the mutant
alleles may remain unchanged.
In addition to the improvement in siRNAs conferring double
knockdown of mutant and wild-type alleles, we also observed an
enhancement of allele discrimination in ASP-RNAi when siRNAs
induced weak knockdown potency, which is in contrast to that of
the siRNAs described above. In that case, forked siRNA duplexes
carrying two nucleotide mismatches at the 39-ends of the sense-
stranded siRNA elements may allow enhanced allele discrimina-
tion between target mutant and wild-type alleles. Since forked
siRNA duplexes appear to increase the assembly of antisense-
strand (guide) siRNA elements into RISCs, the ease of incorpo-
ration of antisense-strand siRNA elements into RISCs may be a
key factor for improvement of ASP-RNAi activity.
Altogether, the evidence presented here suggests that structural
modification by introduction of base substitution into siRNA or
shRNA sequences could influence allele discrimination and
silencing activity in ASP-RNAi.
Mismatches in the seed region and the central position
of miRNAs affect gene silencing
It is noteworthy that destabilization of base-pairing interaction
in the seed region, as well as in the central position, of bona fide
miRNAs appears to also influence recognition and/or suppression
of target RNAs. In the case of miR-196a and miR-196b presented
in this study, the miRNAs appear to induce different levels of
suppression against HOXB8 RNA. Accordingly, it is conceivable
that the difference in gene silencing involving miRNAs could yield
complex regulation of gene expression. Since there are various
base-pairing interactions between miRNAs and their target RNAs,
such interactions may contribute in the generation of various and
complex gene regulatory events. More extensive research is
required to further evaluate this possibility.
Properties of siRNA duplexes conferring ASP-RNAi
Based on the assessed siRNA duplexes efficacy of ASP-RNAi, it
appearsthat differentsiRNAduplexesinduce differentlevelsofASP-
RNAi, suggesting that allele-specific knockdown potencies are most
likely dependent on the designed siRNA sequences. Previous studies
have suggested that functional siRNA duplexes can be characterized
by low base-pairing stability at their 39-ends [29,33–35], i.e., an
asymmetrical feature of base-pairing stability occurs between both
ends of functional siRNA duplexes. From the alignment of the
siRNA sequences examined in the present and previous studies, it
was observed that the siRNA duplexes conferring little or no gene
silencing possessed symmetrical base-pairing stability and contained
G or C residues at many 39-ends of their sense-stranded elements
(supplementary Table s7A): these features are distinct from those of
functional siRNA duplexes. In contrast to the above siRNA
duplexes, most of the siRNA duplexes triggering strong RNAi
activity, including ASP-RNAi, tended to have asymmetrical base-
pairing stability (supplementary Table s7B). It may be of interest to
elucidate the properties of siRNA duplexes that confer strong ASP-
RNAi, other than the asymmetrical feature. To address this,
extensive examination of the knockdown potency of siRNA duplexes
targeting various mutant alleles is required.
Inconclusion, inorder to realizeASP-RNAiagainsttarget mutant
alleles carrying nucleotide variations, the design and evaluation of
competent siRNA duplexes conferring ASP-RNAi is vital; but
designed siRNAs do not always confer potent ASP-RNAi activity.
The evidence presented here suggests that structural modification of
siRNA duplexes by base substitutions may improve ASP-RNAi. The
key regions in an siRNA duplex for such modifications are the
central position, the seed region and the 39-end of the sense-strand
siRNA element, which appear to be related to target RNA cleavage,
target RNA recognition and assembly of the antisense-strand (guide)
Figure 5. Different knockdown potencies against HOXB8
between miR-196a and miR-196b. (A) Nucleotide sequences of
HOXB8 mRNA, miR-196a and miR-196b. The HOXB8 mRNA sequence,
which is nearly complementary to miR-196a, together with mature miR-
196a and miR-196b are aligned. Perfect base-pairing and G:U wobble
base-pairing are indicated by the horizontal bars and dot, respectively.
The mismatched base in miR-196b is indicated in red. (B) Effects of miR-
196a and miR-196b on gene silencing against HOXB8. The miR-196a and
miR-196b duplexes were chemically synthesized, as described previ-
ously [31]. The synthetic miRNA duplexes, together with a reporter
plasmid carrying a part of the HOXB8 gene (see Materials and Methods),
were cotransfected into HeLa cells and the expression of reporter gene
was examined. Ratios of normalized target (Renilla) luciferase activity to
control (Photinus) luciferase activity are shown. Data are averages of at
least three independent experiments. Error bars represent standard
deviations.
doi:10.1371/journal.pone.0002248.g005
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modification of such functional portions of siRNA duplexes may
greatly influence allele discrimination and gene silencing activity,
thereby conferring improvement of ASP-RNAi.
Materials and Methods
Preparation of oligonucleotides
RNA and DNA oligonucleotides were obtained from TAKARA
BIO, and INVITROGEN or BEX, respectively. For preparation of
duplexes, sense- and antisense-strand oligonucleotides (20 mM each)
were mixed and annealed, as described previously [29]. Sequences
of synthesized RNA and DNA oligonucleotides are shown in
supplementary Tables s1, s2, s3, s4, s5 and s6. Non-silencing siRNA
duplex (siControl; Qiagen) was used as the negative control.
Cell culture
HeLa and HEK293 cells were grown at 37uC in Dulbecco’s
modified Eagle’s medium (Wako) supplemented with 10% fetal
bovine serum (Sigma), 100 U/ml penicillin and 100 mg/ml
streptomycin (Wako) in a 5% CO2-humidified chamber. HEK293
cells (Registry No. JCRB9068) were obtained from the Health
Science Research Resources Bank.
Construction of reporter alleles and shRNA expression
plasmids
Reporter alleles were constructed as described previously [17].
Briefly, phRL-TK (Promega) and pGL3-TK [30] plasmids
encoding the Renilla and Photinus luciferase genes, respectively, were
digested with XbaI and NotI, and subjected to ligation with
synthetic oligonucleotide duplexes corresponding to the PRNP-
Figure 6. Schematic summary of allele-specific gene silencing with mismatched siRNA. Guide siRNA elements in RISCs are indicated by
gray bars, in which nucleotide variation and the seed region are indicated by red and blue boxes, respectively. Introduced base substitutions are
indicated by green boxes. Mutant and wild-type allelic transcripts are indicated by red and blue lines, respectively. (A) When designed siRNA
targeting the mutant allele has potential for potent gene silencing, not only the mutant but also the wild-type alleles may be inhibited by RNAi
mediated by the siRNA, i.e., double knockdown against both alleles may occur. (B) When a one-base substitution is introduced into the seed region of
an siRNA conferring double knockdown, the resultant (guide) siRNA generates one and two mismatches against the mutant and wild-type alleles,
respectively, thereby possibly gaining the ability to induce ASP-RNAi.
doi:10.1371/journal.pone.0002248.g006
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alleles (oligonucleotide sequences are indicated in supplementary
Table s3). The resultant plasmids carry allelic PRNP sequences in
the 39-untranslated regions (UTRs) of the luciferase genes
(Figure 1A). The London-type APP mutant and wild-type APP
reporter alleles described in a previous paper [17] were also used.
For construction of shRNA expression vectors, the GeneSilencer
shRNA Vector (Gene Therapy System, Inc.) was used, and
synthetic oligonucleotide duplexes were inserted into the vector
according to the manufacturer’s instructions (oligonucleotide
sequences are indicated in Table s4). To construct a reporter
plasmid carrying part of the HOXB8 sequence, psiCHECK-2
vector (Promega) was digested with XhoI and PmeI, and subjected
to ligation with synthetic HOXB8 oligonucleotide duplex (supple-
mentary Table s3). With regard to expression plasmids carrying a
full-length cDNA of the human PRNP linked with the V5-tag
sequence, the wild-type PRNP cDNA was amplified by RT-PCR
with human brain total RNA (Ambion), trimmed with EcoRI and
NotI, and inserted into the pTracer-EF/Bsd vector (Invitrogen);
the resultant plasmid was designated ‘pPRNPwt-V5’. Using this
plasmid, mutant plasmids carrying the PRNP P102L and P105L
were constructed using the GeneEditor in vitro Site-Directed
Mutagenesis System (Promega) and the QuikChange Site-Directed
Mutagenesis Kit (Stratagene), respectively, according to the
manufacturer’s instructions; the resultant mutant expression
plasmids were designated ‘pPRNPmut102-V5’ and
‘pPRNPmut105-V5’. The PCR primers for PRNP cDNA synthesis
and oligonucleotides used for the mutagenesis were as follows:
For PRNP cDNA synthesis;
Forward PCR primer; 59-TTCCGAATTCGCCACCATGGC-
GAACCTTGGCTGCT-39
Reverse PCR primer; 59-ACATTGCGGCCGCTCCCAC-
TATCAGGAAGATGAGG-39
For site-directed mutagenesis:
PRNP P102L oligo DNA;
59-pGTGGAACAAGCTGAGTAAGCCAA-39
PRNP P105L oligo DNAs;
Forward;
59-GGAACAAGCCGAGTAAGCTAAAAACCAACAT-
GAAGCACATGGC-39
Reverse;
59- GCCATGTGCTTCATGTTGGTTTTTAGCTTACTC-
GGCTTGTTCC-39
Transfection and reporter assay
The day before transfection, cells were trypsinized, diluted with
fresh medium without antibiotics, and seeded into 24-well culture
plates (approximately 0.5610
5 cells/well). Next, 0.24 mg (40 nM)
of siRNA duplexes or 0.1 mg of shRNA vectors together with 0.2
mg of pGL3-TK-backbone plasmid, 0.05 mg of phRL-TK-
backbone plasmid and 0.1 mg of pSV-b-Galactosidase control
vector (Promega) as a control were applied to each well using
Lipofectamine 2000 transfection reagent (Invitrogen) as described
previously [30]. Twenty-four hours after transfection, cell lysate
was prepared and expression levels of luciferase and b-galactosi-
dase were examined using the Dual-Luciferase reporter assay
system (Promega) and Beta-Glo assay system (Promega), respec-
tively, according to the manufacturer’s instructions. The lumines-
cent signals were measured using a TD-20/20 luminometer
(Promega).
Western blotting
The pPRNPwt-V5 or pPRNPmut102(or mut105)-V5 plasmid
(0.1 mg) was cotransfected with siRNA duplex (0.24 mg) or shRNA
expression plasmid (0.1 mg) into HeLa cells. Forty-eight hours after
transfection, cell lysate was prepared and examined by Western
blotting. Equal amounts of cell lysate were separated by SDS-
PAGE and electrophoretically blotted onto PVDF membranes
(Millipore). Membranes were blocked for 1 h in blocking solution
[5% non-fat milk in washing buffer (0.1% Tween-20 in PBS)] and
incubated with anti-V5 antibody (Invitrogen) or anti-a-tubulin
antibody DM1A (Sigma), followed by washing in PBS containing
0.1% Tween-20 and further incubation with horseradish perox-
idase-conjugated donkey anti-mouse IgG (Jackson ImmunoRe-
search Laboratories). Antigen-antibody complexes were visualized
using Immobilon Western reagent (Millipore). The experiments
were duplicated at least twice independently.
Supporting Information
Figure S1 Wild-type and mutant PRNP mRNAs and designed
sense-strand siRNAs. The wild-type and mutant PRNP mRNA
sequences around the P102L (A), P105L (B), and D178N (C)
variations, respectively, are shown and the nucleotide variations
are indicated in red. Designed siRNAs (indicated) are represented
by thin lines and only the variations are indicated in red.
Found at: doi:10.1371/journal.pone.0002248.s001 (0.26 MB TIF)
Figure S2 Expression of the wild-type (A) and P102L (B) PRNP
polypeptides in the presence of indicated siRNAs was examined by
Western blotting as in Figure 2. Expression of alpha-tubulin was
also examined as the control.
Found at: doi:10.1371/journal.pone.0002248.s002 (0.99 MB TIF)
Figure S3 Assessment of mismatched siPrnp102(T10) and
siPrnp178(A9) on ASP-RNAi. (A, D) Nucleotide sequences of
wild-type and mutant PRNP mRNAs and designed siRNAs are
indicated as in Figure 2. (B, E) Assessment of mismatched siRNAs
was carried out and the results are shown as in Figure 2. (C, F)
Western blot analysis of the wild-type PRNP polypeptide
(PRNPwt-V5) in the presence of indicated siRNAs was carried
out as in Figure 2. The PRNPwt-V5 gene was driven by the EF-1a
promoter instead of the CMV promoter in this experiment.
Expression of a-tubulin was also examined as the control.
Found at: doi:10.1371/journal.pone.0002248.s003 (0.61 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0002248.s004 (0.04 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0002248.s005 (0.05 MB
DOC)
Table S3
Found at: doi:10.1371/journal.pone.0002248.s006 (0.03 MB
DOC)
Table S4
Found at: doi:10.1371/journal.pone.0002248.s007 (0.03 MB
DOC)
Table S5
Found at: doi:10.1371/journal.pone.0002248.s008 (0.04 MB
DOC)
Table S6
Found at: doi:10.1371/journal.pone.0002248.s009 (0.03 MB
DOC)
Table S7
Found at: doi:10.1371/journal.pone.0002248.s010 (0.11 MB
DOC)
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